1. Home
  2. ONL vs PLX Comparison

ONL vs PLX Comparison

Compare ONL & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.76

Market Cap

165.4M

Sector

Real Estate

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.43

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
PLX
Founded
2021
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.4M
168.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
ONL
PLX
Price
$2.76
$2.43
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$12.00
AVG Volume (30 Days)
636.1K
679.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.22
Revenue
$147,647,000.00
$52,744,000.00
Revenue This Year
$4.10
$36.81
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
$11.09
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$1.36
52 Week High
$3.04
$3.19

Technical Indicators

Market Signals
Indicator
ONL
PLX
Relative Strength Index (RSI) 44.45 69.03
Support Level $2.62 $2.06
Resistance Level $2.98 $2.66
Average True Range (ATR) 0.11 0.09
MACD -0.01 0.02
Stochastic Oscillator 40.26 98.36

Price Performance

Historical Comparison
ONL
PLX

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: